VAISHALI PHARMA
Back to Balance Sheet
|
VAISHALI PHARMA Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹4.69 Cr | ₹3.86 Cr | ₹6.16 Cr | ₹3.17 Cr | ₹4.30 Cr |
What is the latest Total Non-Current Liabilities ratio of VAISHALI PHARMA ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹4.69 Cr |
| Mar2024 | ₹3.86 Cr |
| Mar2023 | ₹6.16 Cr |
| Mar2022 | ₹3.17 Cr |
| Mar2021 | ₹4.30 Cr |
How is Total Non-Current Liabilities of VAISHALI PHARMA Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹4.69 Cr | 21.59 | |
| Mar2024 | ₹3.86 Cr | -37.30 | |
| Mar2023 | ₹6.16 Cr | 94.04 | |
| Mar2022 | ₹3.17 Cr | -26.16 | |
| Mar2021 | ₹4.30 Cr | - | |
Compare Total Non-Current Liabilities of peers of VAISHALI PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| VAISHALI PHARMA | ₹114.1 Cr | 3.8% | -1.4% | -38.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,773.0 Cr | -6.8% | -7.6% | -4.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,540.0 Cr | -6.6% | -5.8% | 4.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,529.0 Cr | 0.9% | 5.7% | 27.3% | Stock Analytics | |
| CIPLA | ₹111,299.0 Cr | -4.8% | -8.1% | -3.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,393.0 Cr | -2% | -8.8% | -12.9% | Stock Analytics | |
VAISHALI PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VAISHALI PHARMA | 3.8% |
-1.4% |
-38.5% |
| SENSEX | -2% |
-2.8% |
7.4% |
You may also like the below Video Courses